Strain Information | |
---|---|
Image | |
BRC No. | RBRC05698 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | C57BL/6-S100a4<tm1> |
Former Common name | s100A4 flox, B6-S100a4 floxed |
H-2 Haplotype | |
ES Cell line | RENKA [C57BL/6NCrlCrlj] |
Background strain | C57BL/6NCrlCrlj |
Appearance | |
Strain development | Developed by Takaji Matsutani and Norihiro Nishimoto in 2009. RENKA ES cells derived from C57BL/6NCrlCrlj were used. |
Strain description | S100A4 gene floxed mice. |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6NCrlCrlj] |
References |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Frt | yeast FRT (flippase recombination target) site | 3 | Frt | ||||
Frt | yeast FRT (flippase recombination target) site | 3 | Frt | ||||
S100a4 MGI:1330282 | S100 calcium binding protein A4 | 3 | S100a4 <tm1> | targeted mutation 1 | |||
lox71 | mutant lox sequence | 3 | lox71 | ||||
loxP | phage P1 loxP | 3 | loxP | ||||
neo | neomycin resistance gene (Klebsiella pneumoniae) | 3 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Enterobacteria phage P1 LoxP sites, Saccharomyces cerevisiae FRT sites, mouse phosphoglycerate kinase promoter (PGK promoter), Klebsiella pneumoniae (Bacterial transposon Tn5) Neomycine resistance gene, mouse S100a4 genomic DNA |
Research application | Cancer Research Cell Biology Research Cre/loxP system FLP/frt system Immunology and Inflammation Research |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. (will be announced.) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Norihito Nishimoto (Wakayama Medical University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |